Schonfeld Strategic Advisors LLC - TRANSMEDICS GROUP INC ownership

TRANSMEDICS GROUP INC's ticker is TMDX and the CUSIP is 89377M109. A total of 122 filers reported holding TRANSMEDICS GROUP INC in Q3 2021. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.

Quarter-by-quarter ownership
Schonfeld Strategic Advisors LLC ownership history of TRANSMEDICS GROUP INC
ValueSharesWeighting
Q3 2023$246,375
-26.2%
4,500
+13.2%
0.00%
-33.3%
Q2 2023$333,736
-80.6%
3,974
-82.5%
0.00%
-81.2%
Q1 2023$1,721,948
-43.3%
22,738
-53.8%
0.02%
-36.0%
Q4 2022$3,039,154
+153.9%
49,241
+71.6%
0.02%
+150.0%
Q3 2022$1,197,000
+439.2%
28,700
+328.4%
0.01%
+400.0%
Q2 2021$222,0006,7000.00%
Other shareholders
TRANSMEDICS GROUP INC shareholders Q3 2021
NameSharesValueWeighting ↓
Roubaix Capital, LLC 264,438$5,027,0004.84%
Abrams Capital Management 3,499,859$66,532,0002.07%
Sandhill Capital Partners LLC 736,175$13,995,0001.55%
EMERALD ADVISERS, LLC 451,542$8,584,0000.36%
RTW INVESTMENTS, LP 503,266$9,567,0000.36%
EMERALD MUTUAL FUND ADVISERS TRUST 429,868$8,172,0000.33%
NEXT CENTURY GROWTH INVESTORS LLC 107,045$2,034,0000.26%
ELEMENT CAPITAL MANAGEMENT LLC 63,175$1,201,0000.26%
HAMILTON LANE ADVISORS LLC 19,364$368,0000.16%
Harbour Capital Advisors, LLC 20,900$397,0000.15%
View complete list of TRANSMEDICS GROUP INC shareholders